SEC Filing Summary: AspenBio Pharma, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by AspenBio Pharma, Inc. on August 16, 2006. The registrant is incorporated in Colorado. Note: The request metadata referenced "Riot Platforms, Inc.", but the provided filing text explicitly identifies the registrant as AspenBio Pharma, Inc.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that a press release containing results of operations and financial condition was issued on the date of the report.
Material Changes
No specific material changes or comparative financial data are detailed within the text of this Form 8-K. The filing references a press release (Exhibit 99.1) for the actual operational and financial details.
Guidance, Outlook, and Risks
The filing includes Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure), indicating that non-public material information was disclosed via a press release. No specific guidance, outlook, or risk factors are enumerated in the provided text.
Investor Verification Checklist
- Verify the discrepancy between the requested company name (Riot Platforms, Inc.) and the actual registrant in the text (AspenBio Pharma, Inc.).
- Locate and review Exhibit 99.1 (Press Release dated August 16, 2006) to obtain specific financial figures and operational updates.
- Confirm the current corporate status of AspenBio Pharma, Inc., as the filing date is historical (2006).